As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. 

All identified conflicts of interest have been resolved.

Aikaterini Anagnostou, MD – Speaker
Disclosures: Independent Contractor/contracted research: Aimmune

Leonard Bacharier, MD – Speaker
Disclosures: Consultant/consulting fee: AstraZeneca GlaxoSmithKline, Sanofi, Regeneron; Speaker/honoraria: AstraZeneca GlaxoSmithKline, Sanofi, Regeneron, Novartis; 

Aleena Banerji, MD – Speaker
Disclosures: Advisory Board/honorarium: Shire, CSL Behring, Biocryst, Pharming, Pharvaris, Kalvista; Research Grant/honorarium: Biocryst, Shire

Jonathan Bernstein, MD – Speaker
Disclosures: Consultant/consulting fee: ALK, AstraZeneca, Biocryst, CSL Behring, Dyax, Genentech, Novartis, Merck, Regeneron, Sanofi, Shire; Speaker/honoraria: ALK, AstraZeneca, CSL Behring, Dyax, Genentech, Novartis, Regeneron, Sanofi, Shire; Independent Contractor/contracted research: ALK, AstraZeneca, Biocryst, Boehringer Ingelheim, CSL Behring, Dyax, Genentech, Novartis, Merck, Regeneron, Sanofi, Shire, Stallergenes, Teva; Advisory Board/honorarium: ALK, AstraZeneca, Biocryst, CSL Behring, Dyax, Genentech, Novartis, Regeneron, Shire

Michael Blaiss, MD – Speaker
Disclosures: Consultant/consulting fee: Pfizer, Merck, Hycor, ALK, Greer, Sanofi, JDP Therapeutics, PMD Healthcare, DBV Technologies

Karen Hsu Blatman, MD – Speaker
Disclosures: Independent Contractor/contracted research: Takeda

Don Bukstein, MD – Speaker
Disclosures: Speaker/honorarium: AstraZeneca, Aventis, Teva, Sanofi, Regeneron, Genentech, Circassia; Independent Contractor/contracted research – Circassia

Mario Castro, MD – Speaker
Disclosures: Consultant/consulting fee: Novartis, Sanofi, Teva, Genentech; Speaker/honorarium: AstraZeneca, GlaxoSmithKline, Sanofi, Teva, Genentech, Regeneron; Research Study/consulting fee: AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Pulmatrix, Shionogi

William Corrao, MD – Planner, CME Moderator
Disclosures: Speaker/honorarium: GlaxoSmithKline, Boehringer Ingelheim

Ray Davis, MD – Speaker
Disclosures: Consultant/consulting fee: ALK, Baxalta, Shire, Genentech, Novartis, Circassia, Takeda, DBV Technologies, Maculogix; Speaker/honorarium: DBV Technologies, Novartis

Lawrence DuBuske, MD – Speaker
Disclosures: Consultant/consulting fee: ALK, AstraZeneca, Regeneron, Sanofi, Allergy Therapeutics, Abionic; Speaker/honorarium: ALK, AstraZeneca, Novartis, Regeneron, Sanofi; Advisory Board/honorarium: ALK, AstraZeneca, Regeneron, Sanofi

Justin Greiwe, MD – Speaker
Disclosures: Speaker/honorarium: AstraZeneca, Regeneron, Sanofi; Advisory Board/consulting fee: AstraZeneca
  
Jennifer Leiding, MD – Speaker
Disclosures: Consultant/consulting fee: CSL Behring, Horizon Therapeutics; Speaker/honorarium: CSL Behring, Horizon Therapeutics
Advisory Board/consulting fee: CSL Behring, Horizon Therapeutics, Orchard Therapeutics 

Rey Panettieri, Jr., MD – Speaker
Disclosures: Consultant – Novartis, DBV Technologies; Speaker/honorarium: AstraZeneca, Genentech, Sanofi; Advisory Board//consulting fee: AstraZeneca, Medimmune, Research Institute for Fragrance Materials, Equillium, Theravance, Avillion; Independent Contractor/consulting fee: AstraZeneca, Medimmune, Research Institute for Fragrance Materials, Equillium, Genentech, Oncoarendi, Metera

Robert Settipane, MD – CME Planner/Moderator
Disclosures: Independent Contractor/contracted research: AstraZeneca, Chiesi, Genentech, GlaxoSmithKline, Merck, Teva, Novartis, Syneos Health, Biocryst, Avillion

Russell Settipane, MD – CME Planner/Moderator/Speaker/Reviewer
Disclosures: Speaker/honorarium: ALK, Genentech, Regeneron, Teva, Pharming, Shire, Sunovion, Boehringer Ingelheim; Consultant/consulting fees: Boehringer Ingelheim, RB Health; Advisory Board/contracted research: ALK, AstraZeneca, Genentech, GlaxoSmithKline, Regeneron, Sanofi, Teva, Pharming; Independent Contractor/honorarium: AstraZeneca, Chiesi, Genentech, GlaxoSmithKline, Merck, Teva, Syneos Health, Novartis, Biocryst, Avillion

Dana Wallace, MD – Speaker
Disclosures: Consultant/consulting fee: Mylan, Kaleo, Bryan; Speaker/honorarium: Optinose, ALK, Sanofi

The following have no relevant financial relationships to disclose:

Marcella Aquino, MD – Speaker
Joseph Bellanti, MD – Planner/Speaker
William Greisner, III, MD – Planner/Moderator
Katelyn Loiselle, RN – Planner 
Ginny Loiselle – Coordinator
Michael Slaughter, MD – Planner/Moderator